CX-188
/ CytomX
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
May 05, 2021
PROCLAIM-CX-188: A Trial to Find Safe and Active Doses of an Investigational Drug CX-188 for Patients With Solid Tumors
(clinicaltrials.gov)
- P1; N=0; Withdrawn; Sponsor: CytomX Therapeutics; N=54 ➔ 0; Not yet recruiting ➔ Withdrawn
Clinical • Enrollment change • Trial withdrawal • Oncology • Solid Tumor
July 30, 2019
PROCLAIM-CX-188: A Trial to Find Safe and Active Doses of an Investigational Drug CX-188 for Patients With Solid Tumors
(clinicaltrials.gov)
- P1; N=54; Not yet recruiting; Sponsor: CytomX Therapeutics; Initiation date: Jun 2019 ➔ Jan 2020
Clinical • Trial initiation date
March 19, 2019
PROCLAIM-CX-188: A Trial to Find Safe and Active Doses of an Investigational Drug CX-188 for Patients With Solid Tumors
(clinicaltrials.gov)
- P1; N=54; Not yet recruiting; Sponsor: CytomX Therapeutics; Initiation date: Nov 2018 ➔ Jun 2019
Clinical • Trial initiation date
1 to 3
Of
3
Go to page
1